PN-101

BIOLOGICAL2 trials

Sponsors

Paean Biotechnology Inc.

Conditions

DermatomyositisPolymyositis

Phase 1

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

CompletedNCT04976140

Paean Biotechnology Inc.Dermatomyositis, Polymyositis

Start: 2021-12-15End: 2023-10-06Updated: 2024-04-03

Phase 2

Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

Not yet recruitingNCT07122648

Paean Biotechnology Inc.Dermatomyositis, Polymyositis

Start: 2025-12-31End: 2027-04-30Target: 36Updated: 2025-08-14